Abstract
Discovery and development of gene targets for cancer therapeutics are lengthy and highly costly processes. Identification and evaluation of candidate gene targets are of fundamental importance. RNA interference allows candidate genes to be specifically and effectively knocked down in cancer cells. This tool can be easily incorporated into a loss-of-function approach in the initial evaluation of candidate gene targets for cancer treatment prior to moving on to animal studies and clinical trials. This chapter describes a relatively simple and straightforward protocol that makes use of small interfering RNA to achieve knockdown of the candidate gene target and to evaluate the resultant effects on four aspects of cancer cell behavior: migration, invasion, proliferation, and adhesion.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dana H, Chalbatani GM, Mahmoodzadeh H, Karimloo R, Rezaiean O, Moradzadeh A et al (2017) Molecular mechanisms and biological functions of siRNA. Int J Biomed Sci 13(2):48–57
Iravani O, Bay BH, Yip GW (2017) Silencing HS6ST3 inhibits growth and progression of breast cancer cells through suppressing IGF1R and inducing XAF1. Exp Cell Res 350(2):380–389
Schlabach MR, Luo J, Solimini NL, Hu G, Xu Q, Li MZ et al (2008) Cancer proliferation gene discovery through functional genomics. Science 319(5863):620–624
Ahmadzada T, Reid G, McKenzie DR (2018) Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer. Biophys Rev 10(1):69–86
Chen X, Mangala LS, Rodriguez-Aguayo C, Kong X, Lopez-Berestein G, Sood AK (2018) RNA interference-based therapy and its delivery systems. Cancer Metastasis Rev 37(1):107–124
Lai Y, Lim D, Tan PH, Leung TK, Yip GW, Bay BH (2010) Silencing the metallothionein-2A gene induces entosis in adherent MCF-7 breast cancer cells. Anat Rec (Hoboken) 293(10):1685–1691
Vijaya Kumar A, Salem Gassar E, Spillmann D, Stock C, Sen YP, Zhang T et al (2014) HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression. Int J Cancer 135(11):2579–2592
Roussos ET, Condeelis JS, Patsialou A (2011) Chemotaxis in cancer. Nat Rev Cancer 11(8):573–587
Hall DM, Brooks SA (2014) In vitro invasion assay using matrigel: a reconstituted basement membrane preparation. Methods Mol Biol 1070:1–11
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Cory AH, Owen TC, Barltrop JA, Cory JG (1991) Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 3(7):207–212
Oskarsson T (2013) Extracellular matrix components in breast cancer progression and metastasis. Breast 22(Suppl 2):S66–S72
(2003) Whither RNAi? Nat Cell Biol 5(6):489–490
Acknowledgment
We would like to thank S. L. Bay for her help in preparing the illustrations and C. X. Ng for contributing images for Fig. 3. Work in the laboratory of G. W. Yip is supported by Grants NMRC/CSA/0041/2012 and NMRC/CIRG/1436/2015 from the National Medical Research Council, Singapore.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Tan, X.F., Teo, W.X., Yip, G.W. (2019). In Vitro Evaluation of Candidate Gene Targets for Cancer Therapy. In: Dinesh Kumar, L. (eds) RNA Interference and Cancer Therapy. Methods in Molecular Biology, vol 1974. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9220-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9220-1_2
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9219-5
Online ISBN: 978-1-4939-9220-1
eBook Packages: Springer Protocols